[{"data":1,"prerenderedAt":65},["ShallowReactive",2],{"q-nurse-110-2-medical-surgical-038":3},{"subject":4,"subjectSlug":5,"subjectFullName":4,"question":6,"related":34,"lastmod":64},"內外科護理學","medical-surgical",{"id":7,"webId":8,"year":9,"session":10,"subject":4,"number":11,"stem":12,"options":13,"answer":18,"answerNote":19,"images":20,"explanation":21,"explanationDeep":22,"topics":23,"freq":26},"nurse-110-2-內外科護理學-038","nurse-110-2-medical-surgical-038",110,2,38,"有關何杰金氏淋巴瘤的敘述，下列何者錯誤？",{"A":14,"B":15,"C":16,"D":17},"淋巴組織切片中可發現瑞德-史登伯氏細胞（Reed-Sternberg cell）","會侵犯淋巴結、肝臟及脾臟","好發於女性老年人","疾病預後與分期有關","C",null,[],"本題考點在於何杰金氏淋巴瘤的疾病特徵，須挑出錯誤者。何杰金氏淋巴瘤的發病年齡呈雙峰分布，好發於年輕成人(約15至35歲)及五十歲以上者，且男性略多於女性，故C「好發於女性老年人」的敘述錯誤，為本題答案。淋巴組織切片可見特徵性的瑞德-史登伯氏細胞(Reed-Sternberg cell)(A)，是診斷依據，正確。疾病可侵犯淋巴結、肝臟及脾臟(B)，正確。預後與臨床分期(Ann Arbor分期)密切相關(D)，正確。故錯誤者為C。","何杰金氏淋巴瘤特點：Reed-Sternberg細胞(貓頭鷹眼樣雙核)為病理標誌;多由頸部淋巴結無痛腫大開始、依序擴散;B症狀為發燒、夜間盜汗、體重下降。與非何杰金氏淋巴瘤對比：後者無R-S細胞、常為多中心跳躍式擴散、預後較差。分期用Ann Arbor。記憶口訣「何杰金看貓頭鷹細胞、雙峰年齡、循序擴散」。可連結概念：淋巴瘤分期、B症狀、化放療反應。",[24,27,29,32],{"term":25,"count":26},"何杰金氏淋巴瘤",4,{"term":28,"count":10},"Ann Arbor分期",{"term":30,"count":31},"瑞德-史登伯氏細胞",1,{"term":33,"count":31},"雙峰年齡分布",[35,39,44,48,54,59],{"webId":36,"stem":37,"number":38,"year":9,"session":10},"nurse-110-2-medical-surgical-039","有關化學治療特性的敘述，下列何者正確？",39,{"webId":40,"stem":41,"number":42,"year":43,"session":31},"nurse-111-1-medical-surgical-055","有關呼吸器的使用，通常會設定每分鐘數次深呼吸，其所要預防之首要合併症，下列何者正確？",55,111,{"webId":45,"stem":46,"number":47,"year":43,"session":10},"nurse-111-2-medical-surgical-069","有關庫欣氏症候群（Cushing’s syndrome）的飲食指導，下列何者錯誤？",69,{"webId":49,"stem":50,"number":51,"year":52,"session":53},"nurse-112-3-medical-surgical-027","病人剛接受骨髓移植 2 週，主訴右上腹痛，評估有黃疸、腹水，下列何者是病人最有可能發生的問題？",27,112,3,{"webId":55,"stem":56,"number":57,"year":58,"session":31},"nurse-114-1-medical-surgical-031","為降低排斥反應，下列何者為器官移植前進行組織配對的常見檢驗？①C型肝炎檢驗             ②人類白血球抗原（HLA）   ③混和性淋巴細胞反應    ④交叉配對試驗    ⑤人類免疫缺乏病毒（HIV）篩檢",31,114,{"webId":60,"stem":61,"number":62,"year":63,"session":10},"nurse-115-2-medical-surgical-025","有關化學治療藥物滲漏之處理方式，下列何者最不適當？",25,115,"2026-09-04",1788510729129]